scholarly article | Q13442814 |
P356 | DOI | 10.1136/GUTJNL-2011-300256 |
P698 | PubMed publication ID | 21757451 |
P50 | author | Bruce E. Sands | Q29922058 |
P2093 | author name string | Joshua R Korzenik | |
Garret Cullen | |||
Caroline Bader | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
inflammatory bowel diseases | Q917447 | ||
P304 | page(s) | 385-391 | |
P577 | publication date | 2011-07-13 | |
P1433 | published in | Gut | Q5621669 |
P1476 | title | Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease | |
P478 | volume | 61 |
Q39029698 | ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease |
Q30424165 | AID in aging and autoimmune diseases. |
Q38593255 | Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications |
Q41489713 | Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial |
Q46205741 | Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis |
Q38372800 | Effects of immunosuppressants on immune response to vaccine in inflammatory bowel disease |
Q38995105 | European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly |
Q40600058 | Guidelines for vaccination of immunocompromised individuals |
Q30417659 | Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. |
Q33842375 | Immunizations in children with inflammatory bowel disease treated with immunosuppressive therapy |
Q40560538 | Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study |
Q36384717 | Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment |
Q64234383 | Improving immunization strategies in patients with inflammatory bowel disease |
Q36493907 | Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate |
Q88210760 | Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients |
Q34008766 | Preventing infective complications in inflammatory bowel disease |
Q38026405 | Prevention and management of infectious complications in IBD. |
Q64240358 | Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease |
Q91706575 | Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease |
Q90027672 | The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease |
Q40850064 | Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study |
Q35188575 | Updates in vaccination: recommendations for adult inflammatory bowel disease patients |
Q43169911 | Uptake of influenza vaccine in ulcerative colitis |
Q89947372 | Uselessness of Serum p53 Antibody for Detecting Colitis-associated Cancer in the Era of Immunosuppressive Therapy |
Q42246321 | Utilization of influenza immunization in adults with Crohn's disease-a longitudinal, population-based study |
Q38243693 | Vaccinating the inflammatory bowel disease patient |
Q36496958 | Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. |
Q38082568 | Vaccination strategies in patients with IBD. |
Q36699251 | Vaccines and recommendations for their use in inflammatory bowel disease |
Q38202639 | Varicella zoster virus infection in patients with inflammatory bowel disease |
Search more.